Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions
- Recurrent Adult Diffuse Large Cell Lymphoma
- Recurrent Grade 3 Follicular Lymphoma
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Transformed Recurrent Non-Hodgkin Lymphoma
Interventions
- DRUG: Buparlisib
- OTHER: Laboratory Biomarker Analysis
- OTHER: Questionnaire Administration
Sponsor
Mayo Clinic
Collaborators